Ellis and Everard has named Paul Symmons as managing director of its UK operations. He joins the company from ICL, where he was director of global supply chain management.
Bruno Angelici is to take over as vice-president for international sales and marketing at AstraZeneca. Martin Wright will succeed him as vice president for Japan.
FMC has elected William Walter as executive vice-president in charge of its speciality, industrial chemicals and agrochemicals operations. He will also serve on the board.
Tony Baxter has been named chief executive of Argenta Discovery, a new UK firm which converts leads from high-throughput screening into patentable substances.
ICN Pharmaceuticals has appointed former Canadian prime minister Kim Campbell to its board. She has recently completed a term as Canada's Counsel General in Los Angeles.
Donald Buxton is to join the board at Forbes Medi-Tech. He is currently chairman of r and d company Labopharm, and was previously president of Roussel Canada.
David Stoute, currently co-president of GlaxoSmithKline's US pharmaceutical operations, is to assume sole responsibility for the business.
David Jackson is to head the project engineering group at Extract Technology, while Paul Boldy takes on the modular building and pharmaceutical facility projects.
E-commerce specialist eGlobalChem has appointed James Alampi to its advisory board. He was chief executive of e-Chemicals.com, and advises Deloitte Consulting.
